Join a Pregnancy Study on Mayzent® & Kesimpta®

We’re collecting info on Mayzent® & Kesimpta® When Taken During Pregnancy

MotherToBaby is currently enrolling participants into an observational study examining the use of Mayzent® during pregnancy and Kesimpta® (ofatumumab) when taken shortly before or during pregnancy. Our studies are strictly observational, which means we will never ask you to take any new medicines, experimental drugs or to change any part of your healthcare routine. If you enroll, you’ll simply be followed by our team through the remainder of your pregnancy, and your baby will be followed for a period of time after birth.

Our goal is to provide parents and their health providers with the evidence-based information that they need to make more informed healthcare decisions during pregnancy. To do that, we need your help. If you have multiple sclerosis and have taken Mayzent® during pregnancy or Kesimpta® (ofatumumab) at any point in your current pregnancy, or 3 months prior to pregnancy, you may qualify for this important study.

Questions?

To connect with our research team, please contact us at

Phone | 877.311.8972
Email | mothertobaby@health.ucsd.edu

We’re open Monday – Thursday from 7am – 7pm and Friday 7am – 6pm Pacific, excluding public holidays.

You can also visit our Frequently Asked Questions to learn more about participating in our studies.


How Our Studies Work

MotherToBaby Computer Icon

Parent-To-Be Enrolls in Study 

MotherToBaby File Icon

We Gather Info about the Pregnancy 

MotherToBaby Insights Icon

Discoveries & Insights Gained 

What’s Involved?

Our study includes:
• 1-3 phone interviews during your pregnancy and at least 1 interview after you have your baby.
• Your permission to obtain a copy of your medical records from your healthcare provider for your pregnancy and for your child through 1 year of age.
• An opportunity to receive a specialized, non-invasive exam of your baby with a study doctor
• An online neurodevelopmental assessment that can also provide insight into the child’s development at approximately 12 months of age

All the information we request will be kept confidential. Your privacy is important to us. We comply with strict regulations
and laws set forth by state and federal agencies as well as the Institutional Review Board (IRB) at the University of
California, San Diego, who oversees and monitors our research. Since we ask for your permission to obtain medical
records, we will also give you detailed information on how this data will be used and how we will protect your privacy.


MotherToBaby Pregnancy Women Intro Block

What is a MotherToBaby Pregnancy Study?

MotherToBaby Pregnancy Studies is a research program seeking to understand how certain medications, vaccines, or health conditions may affect pregnancy. Our research will help people who are pregnant and/or breastfeeding and health providers make informed treatment decisions. All of our studies are observational: we will never ask someone to take or change any aspect of their current health routine.

Who Leads MotherToBaby Pregnancy Studies?

Christina Chambers, PhD, MPH is the lead investigator for MotherToBaby Pregnancy Studies, which are coordinated by UC San Diego’s Center for Better Beginnings. She is a world‐renowned perinatal epidemiologist and a Professor of Pediatrics and Family and Preventive Medicine at the UC San Diego. Her interests are in the areas of birth defects and other pregnancy outcomes, with a special focus on exposures that can cause birth defects.

“Every person deserves to know if their health conditions or the medication they need to take could affect their baby during pregnancy. We are committed to bringing you better information for healthier outcomes.”

– Christina Chambers, PhD, MPH


If you are interested in joining the study, please submit your interest below. Our research team will contact you to see if you qualify. Your information is confidential.


If you are a health professional, please fill out the Refer a Patient form and we will contact your patient to see if they qualify. Your information is confidential.

Questions? Call 866.626.6847 | Text 855.999.3525 | Email or Chat at MotherToBaby.org.


Disclaimer: MotherToBaby Fact Sheets are meant for general information purposes and should not replace the advice of your health care provider. MotherToBaby is a service of the non-profit Organization of Teratology Information Specialists (OTIS). OTIS/MotherToBaby encourages inclusive and person-centered language. While our name still contains a reference to mothers, we are updating our resources with more inclusive terms. Use of the term mother or maternal refers to a person who is pregnant. Use of the term father or paternal refers to a person who contributes sperm. Copyright by OTIS, December 13, 2022.